Carla Riera-Domingo

10PUBLICATIONS
120CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biochemistry - lipidsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 16, 2026
Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

|Mar 22, 2023
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding.

Carla Riera-Domingo, Eduarda Leite-Gomes, Iris Charatsidou

|Feb 02, 2023
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling.

Patricia Altea-Manzano, Ginevra Doglioni, Yawen Liu

|Jun 27, 2022
Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix.

Emily J Kay, Karla Paterson, Carla Riera-Domingo

|May 18, 2022
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.

Matteo Rossi, Patricia Altea-Manzano, Margherita Demicco

|Feb 12, 2022
PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index.

Andrea Casazza, Lawrence Van Helleputte, Britt Van Renterghem

Pageof 2

Frequent Collaborators

5 joint publications

Morag Park

4 joint publications

Margherita Demicco

4 joint publications

Juan Fernández-García

4 joint publications

Ginevra Doglioni